We detected higher TNF mRNA levels in PBMCs from patients with lung cancer compared to healthy control subjects (Figure 3F), suggesting enhanced inflammatory activity in the peripheral blood and indicating a systemic immune response associated with lung cancer. The gene discussed is TNF; the disease is lung carcinoma.